Services on Demand
Journal
Article
Related links
Share
Revista Uruguaya de Medicina Interna
Print version ISSN 2393-6797On-line version ISSN 2393-6797
Abstract
PEREZ, Laura et al. Fibroscan as a diagnosis of portal hypertension in cirrhotic patients. Rev. Urug. Med. Int. [online]. 2019, vol.4, n.3, pp.26-34. Epub Dec 01, 2019. ISSN 2393-6797. https://doi.org/10.26445/04.03.3.
Introduction:
Portal hypertension is a syndrome that is frequently present in chronic liver diseases. Within the causes that results in portal hypertension, liver cirrhosis outstands, being responsible for most cases. Since the incorporation of transient elastography (Fibroscan) in Uruguay, no research has been conducted at a national level that correlates the results obtained by Fibroscan with the presence of portal hypertension in cirrhotic patients.
Objectives:
To characterize cirrhotic population diagnosed by Fibroscan who are assisted in the Hepatology polyclinic of Hospital Pasteur.
Material and Methods:
Patients with diagnosis of liver cirrhosis of any etiology were studied, who have been assisted and monitored in the Hepatology polyclinic of Hospital Pasteur in the period 2015 - 2018.
Results:
49 patients were included, of which 34 presented elements of portal hypertension. A higher prevalence of cirrhosis was found in men with alcoholic etiology and infection with hepatitis C virus. An association was found between Fibroscan values ≥ 15 kPa and the presence of portal hypertension. It was not possible to demonstrate a statistically significant association between Fibroscan values ≥ 15 kPa and the presence of gastric esophageal varices and/or gastropathy due to portal hypertension.
Conclusions:
The cut-off point used in Fibroscan is useful for the diagnosis of portal hypertension. It is necessary to continue performing fibrogastroscopy for the diagnosis of portal hypertension.
Keywords : Portal hypertension; transient elastography; liver cirrhosis; esophageal varices..